Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: SATO VICKI L (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1669110	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$1.49	2027-10-05	Common Stock (42377)		Direct
Stock Options (Right to Buy)	$5.18	2029-03-11	Common Stock (160666)		Direct

Footnotes

F1: The option vests and becomes exercisable in 36 equal monthly installments following the grant date of October 5, 2017.

F2: 1/4 of the shares subject to the stock option vested and became exercisable on August 1, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.